Spider silk and iron oxide nanoparticles show promise for theranostic cancer applications Aug. 29, 2019
2,3,6-Trisubstituted pyridine-containing M4 PAM shows selectivity and preclinical efficacy Aug. 29, 2019
Merck & Co. describes heme-displacing inhibitors of IDO-1 with enhanced target engagement Aug. 29, 2019
Celgene identifies CELMoD compounds for treating relapsed and refractory multiple myeloma Aug. 29, 2019
RSS